8 years treating AML
AML patients treated annually
Dr. Blachly's research focus is on genomics and gene transcription in leukemia and its relevance in experimental therapeutics. His work explores whether and how mutations and transcriptional attributes can be studied in the context of clinical trials to provide prognostic and predictive information relevant to novel anticancer therapies.
The Ohio State University Comprehensive Cancer Center:
460 W 10th Ave, Columbus, OH 43210, USA
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life
AML stories, AML clinical trials, AML 101 articles and events with AML
Thanks to our HealthTree Community for AML Sponsors: